ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new daily pill, NKT3964, in adults with advanced solid tumors (like ovarian, endometrial, breast, lung, or stomach cancer) that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose, whi…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Could a drug already approved for some cancers help people with rare tumors?
Disease control Recruiting nowThis study tests a drug called atezolizumab in people with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). The drug is already approved for certain cancers, and researchers want to see if it works for other cancer types with these ge…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control Recruiting nowThis study tests a new drug, LY3537982, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if the drug is safe and shrinks tumors. About 540 participants with lung, colorectal, endometrial, ovarian, pancreatic, or bile du…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC